(Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant, a novel, once-daily oral ...

Excessive hair growth can be embarrassing and frustrating. Learn the underlying causes of unwanted hair growth in women and ...

Dana Pizzuti, the Chief Medical (TASE:PMCN) and Development Officer of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), recently executed a series of stock transactions as disclosed in a recent SEC ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

Tokio Marine Asset Management Co. Ltd. cut its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.8% ...

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shares fell 5.5% during trading on Monday following insider selling activity. The company traded as low as $32.48 and last traded at $32.33.

David W. Boyer, the Chief Corporate Affairs Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a biopharmaceutical company ...

such as late-onset congenital adrenal hyperplasia and Cushing's syndrome. The more recent 2003 Rotterdam consensus workshop was in response to an increasing awareness that the clinical expression ...

Hypoglycaemia may indicate cortisol deficiency secondary to hypothalamic-pituitary or adrenocortical insufficiency. The state of hydration and blood pressure should be assessed as various forms of ...

Congested skin is a common issue that occurs when dead skin cells, oil, sweat, and dirt block the pores, leading to a dull appearance or acne. Here’s what you can do to treat it.